标普和纳斯达克内在价值 联系我们

Alpha Tau Medical Ltd. DRTSW NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • IL • USD

SharesGrow Score
40/100
1/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Alpha Tau Medical Ltd. (DRTSW) — This stock currently has no analyst coverage. No price targets, ratings, or earnings estimates are available. This is common for preferred shares, warrants, OTC-traded securities, and smaller companies that are not followed by Wall Street analysts.

分析师预估 每股收益(EPS)为 $-0.45 和 营收为 $0.00B (下一财年).

每股收益(EPS)历史表现: 2024: 实际 $-0.45 vs 预期 $-0.45 (超预期 +0%). 2025: 实际 $-0.53 vs 预期 $-0.51 (不及预期 -3.8%). 分析师准确度: 98%.

EPS 预测 — DRTSW

98%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual –$0.45 vs Est –$0.45 ▼ 0.0% off
2025 Actual –$0.53 vs Est –$0.51 ▼ 3.7% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.

营收预测 — DRTSW

Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
联系我们
🎓
SharesGrow 学院
学习如何计算内在价值,发现被低估的股票。
每周在线课程
给我们留言